Hillsdale Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-375
Closed -$74K 549
2014
Q1
$74K Buy
+375
New +$70.8K 0.02% 409

Other funds holding CLB

Hillsdale Investment Management's CLB Position: Q2 2014 in Review

Hillsdale Investment Management sold out of Core Laboratories (CLB) in Q2 2014, closing a stake of 375 shares — an estimated $74K sold.

Hillsdale Investment Management first reported a position in CLB in Q1 2014 and held it in 1 quarter. The position peaked at $74K in Q1 2014. 346 funds tracked by Wall St. Rank hold CLB as of Q2 2014.

  • Hillsdale Investment Management reported no remaining Core Laboratories position as of Q2 2014 after selling out during the quarter.
  • Hillsdale Investment Management sold 375 Core Laboratories shares in Q2 2014, an estimated $74K.
  • Hillsdale Investment Management first reported a position in Core Laboratories in Q1 2014 and held it in 1 quarter.
  • Hillsdale Investment Management's Core Laboratories position peaked at $74K in Q1 2014.
  • 346 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2014.

Based on Hillsdale Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.